Showing 1 of 1 recruiting trials for “oculocutaneous-albinism-type-1”
Safety and Efficacy of a Single Suprachoroidal Injection of JWK010 Gene Therapy in Subjects With Oculocutaneous Albinism Type 1 (OCA1)
👨⚕️ Fang Lu, Department of Ophthalmology, West China Hospital, Sichuan University📍 1 site📅 Started Dec 2025View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →